Pemigatinib-associated calcinosis cutis: First case of complete regression with continued phosphate chelator therapy - 20/09/24
Doi : 10.1016/j.annder.2024.103304
P.-L. Chantreau
Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, 37044 Tours, France
E. Lebidre
Department of Dermatology, Université de Tours, Centre Hospitalier Universitaire de Tours, 37044 Tours, France
M. Tallegas
Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, 37044 Tours, France
Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, 37044 Tours, France
F. Dujardin
Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, 37044 Tours, France
M. Samimi
Department of Dermatology, Université de Tours, Centre Hospitalier Universitaire de Tours, 37044 Tours, France
T. Kervarrec ⁎ 
Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, 37044 Tours, France
⁎Corresponding author at: Department of Pathology, Hôpital Trousseau, CHRU de Tours, 37044 Tours cedex 9, France.Department of PathologyHôpital TrousseauCHRU de ToursTours cedex 937044France
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| ☆ | Institutional Review Board: The study was approved by the Tours (France) Ethics Committee for Human Research (No. ID RCB2009-A01056-51). |
© 2024
Elsevier Masson SAS. Tutti i diritti riservati.
Vol 151 - N° 3
Articolo 103304- settembre 2024 Ritorno al numero
Articolo precedente
- Squamous cell carcinoma on vitiligo in a dark-skinned patient
- Khadim Diop, M.-T. Ndiaye, K. Dansokho, F. Diassé, M. Sarr, S. Diadie, B.A. Diatta, B. Seck, M. Ndiaye, A. Diop, M. Diallo, F. Ly, S.-O. Niang
- Severe cholinergic urticaria: Clinical characteristics and therapeutic approach
- J. Castagna, F. Tetart, A. Badaoui, E. Amsler, P. Pralong, F. Castelain, J. Delaunay, A. Soria, French urticaria group GUS
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?